Drug-Drug Interaction (DDI) Study for TD-9855
Clinical trial NCT03432793 · COMPLETED
Trial details
- NCT number
- NCT03432793
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2018-04-21
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.